On July 20, 2021, the Second International Commercial Court held a public hearing on a dispute over the liability for infringing upon company interests between Plaintiff Beta Pharmaceuticals Co., Ltd. and Defendant Beta Pharma, Inc., Don Xiaodong Zhang, and Beta Pharma (SHANGHAI), Inc..
It is a first-instance international commercial case arising from R&D in pharmaceuticals and international investment. Due to its influence and typical significance, the Supreme People's Court considered the case appropriate to be tried by the CICC, with a ruling that the case should be heard by the Second International Commercial Court.
The case was heard by a five-judge panel, including Judge Shen Hongyu, Judge Zhu Li, Judge Ren Xuefeng, Judge Yu Xiaohan, and Judge Guo Zaiyu. The decision will be rendered at a later date.
July 20, 2021
*The original text is Chinese and has been translated into English for reference only. If there is any inconsistency or ambiguity between the Chinese version and the English version, the Chinese version shall prevail.